The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Stopped early · Phase 1

Conditions studied: Advanced Malignancies

In brief

To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.

Key facts

Study ID

NCT00468260

Run by

Novartis Pharmaceuticals

People needed

12

Starts

2007-05-01

Last updated by the study team

2009-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Known diagnosis of human immunodeficiency virus (HIV) infection, hepatitis
• Female patients who are pregnant or breast feeding
• Patients with a severe and/or uncontrolled medical disease
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.